Dr. Jaideep Chunduri of Beacon Orthopedics & Sports activities Medication in Cincinnati, OH makes use of HOLO Portal, the world’s first synthetic intelligence (AI)-driven, augmented actuality (AR) steerage system for spine surgical procedure
DEERFIELD, Ailing., Sept. 15, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a worldwide medical know-how firm centered on elevating the usual of care by driving the evolution of digital well being, as we speak introduced additional development within the commercialization of its HOLO Portal™ surgical steerage system. The Firm is happy to report that Jaideep Chunduri, MD, a board licensed orthopaedic and spinal surgeon at Beacon Orthopedics & Sports activities Medication in Cincinnati, Ohio, carried out his first case with the HOLO Portal surgical steerage system.
HOLO Portal, the world’s first surgical steerage system to include AI and AR, represents the preliminary scientific software of Surgalign’s HOLO™ AI digital well being platform. The system’s AI processes intraoperative photographs to autonomously phase and label the anatomy and plan patient-specific pedicle screw trajectories which can be accredited by the surgeon. The HOLO Portal system makes use of AR to overlay the segmented AI reconstruction over the affected person’s precise anatomy, offering real-time 3D visualization all through the surgical process. This AR show helps surgeons visualize trajectories and information surgical devices.
“The constancy of the holographic surgical show is kind of wonderful, and the AI deliberate screws have been proper the place I needed them. HOLO Portal is actually next-generation know-how, and even higher it’s simple and intuitive to undertake right into a surgical method,” said Dr. Chunduri, who joined Beacon Orthopedics & Sports activities Medication in 2003. “Synthetic intelligence and augmented actuality promise to make surgical procedure extra environment friendly and safer, which is finally why I selected to combine HOLO Portal into my observe.”
In January 2022, the Firm acquired U.S. Food & Drug Administration (FDA) 510(ok) clearance to be used of the HOLO Portal surgical steerage system inside lumbar spine procedures. The Firm is presently increasing the system’s restricted market launch and intends to additional enhance web site areas all year long. As instances are carried out and information is accrued, the Firm plans to combine new functions on its platform with the objective to each advance the standard of care and enhance outcomes for sufferers.
“Congratulations to Dr. Chunduri for finishing his first surgical case with the SurgalignTM HOLO Portal system,” mentioned Terry Wealthy, President and CEO of Surgalign. “The efficiency to this point of the HOLO Portal system and the surgeon pleasure generated by the know-how have validated our excessive expectations. We consider that our HOLO AI know-how will remodel affected person outcomes, and we couldn’t be prouder to companion with Dr. Chunduri.”
About Surgalign Holdings, Inc. Surgalign Holdings, Inc. is a worldwide medical know-how firm dedicated to the promise of digital well being to drive transformation throughout the surgical panorama. Uniquely aligned and resourced to advance the usual of care, the corporate is constructing applied sciences physicians and different well being suppliers will look to for what is actually doable for his or her sufferers. Surgalign is targeted on growing options that predictably ship superior scientific and financial outcomes. Surgalign markets merchandise all through the USA and in roughly 50 international locations worldwide by way of an increasing community of prime unbiased distributors. Surgalign is headquartered in Deerfield, IL, with business, innovation and design facilities in San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany. Be taught extra at www.surgalign.com and join on LinkedIn and Twitter.
Ahead Trying Assertion This press launch comprises forward-looking statements primarily based on administration’s present expectations, estimates and projections about our merchandise, firm, and business, our administration’s beliefs, and sure assumptions made by our administration. Phrases resembling “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and different variations of such phrases and comparable expressions are meant to determine such forward-looking statements. Ahead-looking statements embrace statements concerning the options, capabilities and advantages of the HOLO Portal system. These statements are usually not ensures of future efficiency and are topic to dangers and uncertainties, together with the dangers described in our public filings with the U.S. Securities and Change Fee (SEC). Our precise outcomes might differ materially from the anticipated outcomes mirrored in these forward-looking statements. Copies of the corporate’s SEC filings could also be obtained by contacting the corporate or the SEC or by visiting Surgalign’s web site at www.surgalign.com or the SEC’s web site at www.sec.gov.